BUY Krishna Institute of Medical Sciences Limited — Prabhudas Lilladher
byPrabhudas LilladherHorizon: NA (inferred 1 year)19 May 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·8 Jun · today
2 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·10 Feb · 4mo ago
Krishna Institute of Medical Sciences Limited announced its audited financial results for the quarter and financial year ended March 31, 2026. The results will be available on the company's website.
NSE · Press Release·16 May · 3w ago
Krishna Institute of Medical Sciences Ltd announced its audited financial results for the quarter and financial year ended March 31, 2026. The results include details on revenue, EBITDA, and PAT for b
BSE · Company Update·16 May · 3w ago
Krishna Institute of Medical Sciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
NSE · Outcome of Board Meeting·15 May · 3w ago
Krishna Institute of Medical Sciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
NSE · Outcome of Board Meeting·15 May · 3w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Krishna Institute of Medical Sciences
- BUY — Jigar S Patel, Anand Rathi19 Oct 2026 · ~3 months · target ₹800 · Active
- BUY — HSBC Securities9 Oct 2026 · ~1 year · target ₹865 · Active
- BUY — Goldman Sachs1 Oct 2026 · ~1 year · target ₹1,000 · Active
- BUY — Emkay Global1 Oct 2026 · ~1 year · target ₹850 · Active
- BUY — Rakesh Bansal24 Sept 2026 · ~2 weeks · target ₹831 · SL hit
More from Prabhudas Lilladher
- BUY Sai Life Sciences21 Oct 2026 · ~1 year · target ₹1,620 · Active
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹200 · Active
- BUY Nestle India15 Oct 2026 · ~1 year · target ₹1,526 · Active
- BUY Tata Elxsi14 Oct 2026 · ~1 year · target ₹3,790 · Target hit
- SELL Avenue Supermarts12 Oct 2026 · ~3 months · target ₹3,214 · Target hit

